ClinicalTrials.Veeva

Menu

Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room (Step down ward)

S

Siriraj Hospital

Status

Not yet enrolling

Conditions

Multiple Myeloma

Study type

Observational

Funder types

Other

Identifiers

NCT06286241
877/2564(IRB2)

Details and patient eligibility

About

The goal of this observational study is to comparison of the complications in multiple myeloma patients who received autologous stem cell transplantation between in HEPA-filtered room and non-HEPA-filtered room. The main questions it aims to answer are:

  • The incidence of febrile neutropenia, infection, and duration of hospital stay
  • 2-year progression free survival Participants will be collected the data of baseline diagnosis, treatment, treatment results and complications during admission and follow-up visits from hospital medical record.

Enrollment

344 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aged 18 - 65 years old
  • Patients with multiple myeloma undergoing treatment with autologous stem cell transplantation and having a Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) score less than or equal to 2
  • Patients must provide signed consent to participate in the research if they undergo ASCT after the study has been approved.
  • If patients undergo ASCT before the study approval, retrospective data will be collected.

Exclusion criteria

  • Patients with concomitant other types of cancer
  • Patients who refuse to participate in the study.

Trial design

344 participants in 2 patient groups

HEPA-filtered room
Description:
multiple myeloma patients who received autologous stem cell transplantation were admitted in HEPA-filtered room
non-HEPA-filtered room
Description:
multiple myeloma patients who received autologous stem cell transplantation were admitted in non-HEPA-filtered room

Trial contacts and locations

0

Loading...

Central trial contact

Weerapat Owattanapanich, MD; Chutima Kunacheewa, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems